Correlation Between Cns Pharmaceuticals and Immutep

Can any of the company-specific risk be diversified away by investing in both Cns Pharmaceuticals and Immutep at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cns Pharmaceuticals and Immutep into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cns Pharmaceuticals and Immutep Ltd ADR, you can compare the effects of market volatilities on Cns Pharmaceuticals and Immutep and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cns Pharmaceuticals with a short position of Immutep. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cns Pharmaceuticals and Immutep.

Diversification Opportunities for Cns Pharmaceuticals and Immutep

0.76

Correlation Coefficient

Cns Pharmaceuticals  Immutep

Poor diversification

The 3 months correlation between Cns and Immutep is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Cns Pharmaceuticals and Immutep Ltd ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immutep Ltd ADR and Cns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cns Pharmaceuticals are associated (or correlated) with Immutep. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immutep Ltd ADR has no effect on the direction of Cns Pharmaceuticals i.e., Cns Pharmaceuticals and Immutep go up and down completely randomly.

Pair Corralation between Cns Pharmaceuticals and Immutep

Given the investment horizon of 90 days Cns Pharmaceuticals is expected to under-perform the Immutep. In addition to that, Cns Pharmaceuticals is 5.06 times more volatile than Immutep Ltd ADR. It trades about -0.14 of its total potential returns per unit of risk. Immutep Ltd ADR is currently generating about -0.09 per unit of volatility. If you would invest  208.00  in Immutep Ltd ADR on December 28, 2024 and sell it today you would lose (26.00) from holding Immutep Ltd ADR or give up 12.5% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Cns Pharmaceuticals  vs.  Immutep Ltd ADR

Cns Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Immutep Ltd ADR

Risk-Adjusted Performance

Very Weak

Over the last 90 days Immutep Ltd ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's primary indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Pair Trading with Cns Pharmaceuticals and Immutep

The main advantage of trading using opposite Cns Pharmaceuticals and Immutep positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cns Pharmaceuticals position performs unexpectedly, Immutep can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immutep will offset losses from the drop in Immutep's long position.

The idea behind Cns Pharmaceuticals and Immutep Ltd ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.